BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 20518359)

  • 1. Actinic keratoses: past, present and future.
    Fenske NA; Spencer J; Adam F
    J Drugs Dermatol; 2010 May; 9(5 Suppl ODAC Conf Pt 1):s45-9. PubMed ID: 20518359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solar keratoses: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
    Schmitt AR; Bordeaux JS
    Clin Dermatol; 2013; 31(6):712-7. PubMed ID: 24160275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current management of actinic keratoses.
    Shoimer I; Rosen N; Muhn C
    Skin Therapy Lett; 2010 May; 15(5):5-7. PubMed ID: 20505896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and treatment of actinic keratosis].
    Isoherranen K; Koskenmies S; Overmark M; Ylitalo L; Saksela O; Pitkänen S
    Duodecim; 2015; 131(9):863-70. PubMed ID: 26237885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New and emerging topical approaches for actinic keratoses.
    Del Rosso JQ
    Cutis; 2003 Oct; 72(4):273-6, 279. PubMed ID: 14604078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agreement on the clinical diagnosis and management of cutaneous squamous neoplasms.
    Terushkin V; Braga JC; Dusza SW; Scope A; Busam K; Marghoob AA; Gill M; Halpern AC
    Dermatol Surg; 2010 Oct; 36(10):1514-20. PubMed ID: 20698872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New and emerging treatments for nonmelanomas and actinic keratoses.
    Peterson SR; Goldberg LH
    J Drugs Dermatol; 2003 Aug; 2(4):429-32. PubMed ID: 12884470
    [No Abstract]   [Full Text] [Related]  

  • 8. Key Opinion Leader (KOL) Consensus for actinic keratosis management in Italy: the AKTUAL Workshop.
    Peserico A; Neri L; Calzavara Pinton P; Catricalà C; Pellacani G; Peris K; Pimpinelli N
    G Ital Dermatol Venereol; 2013 Oct; 148(5):515-24. PubMed ID: 24005145
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of action of new treatment modalities for actinic keratosis.
    Berman B; Villa AM; Ramirez CC
    J Drugs Dermatol; 2006 Feb; 5(2):167-73. PubMed ID: 16485885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical and light-based treatments for actinic keratoses.
    Silapunt S; Goldberg LH; Alam M
    Semin Cutan Med Surg; 2003 Sep; 22(3):162-70. PubMed ID: 14649583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Treatment Guidelines for Actinic Keratosis: A Critical Appraisal and Review.
    Fleming P; Zhou S; Bobotsis R; Lynde C
    J Cutan Med Surg; 2017; 21(5):408-417. PubMed ID: 28510496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapeutic management of actinic keratosis: focus on newer topical agents.
    Samrao A; Cockerell CJ
    Am J Clin Dermatol; 2013 Aug; 14(4):273-7. PubMed ID: 23640424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic Keratoses.
    Poulin Y; Lynde CW; Barber K; Vender R; Claveau J; Bourcier M; Ashkenas J;
    J Cutan Med Surg; 2015; 19(3):227-38. PubMed ID: 25926621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications.
    Feldman SR; Fleischer AB
    Cutis; 2011 Apr; 87(4):201-7. PubMed ID: 21644496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of actinic keratoses.
    Lang PG
    Compr Ther; 2003; 29(2-3):108-14. PubMed ID: 14606340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Actinic keratoses].
    Hommel T; Szeimies RM
    Hautarzt; 2016 Nov; 67(11):867-875. PubMed ID: 27613022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical therapy for actinic keratoses, II: Diclofenac, colchicine, and retinoids.
    Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
    Cutis; 2003 May; 71(5):373-9. PubMed ID: 12769404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.
    Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
    Cutis; 2003 May; 71(5):365-70. PubMed ID: 12769403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What's new in the treatment of actinic keratoses?
    Frankel A; Goldenberg G
    Cutis; 2011 Feb; 87(2):62-4. PubMed ID: 21416769
    [No Abstract]   [Full Text] [Related]  

  • 20. Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses.
    Dirschka T; Bierhoff E; Pflugfelder A; Garbe C
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):258-63. PubMed ID: 19709346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.